Furthermore, the clinical relevance of ABCB1 is underscored by the discovery of an APE1/YB-1/ABCB1 gene signature associated with adverse outcomes, a finding supported by significant co-expression of YB-1 and ABCB1 in a cohort of 22 MM patients [57]. Here, YBX1 is linked to Miyoshi myopathy.